Global Haemorrhagic Stroke Treatment Market to Grow at a CAGR of 6.20% During the Period 2026-2035, Driven by Cases of Haemorrhagic Stroke, Particularly in Low and Middle Income Countries (LMIC)

The global haemorrhagic stroke treatment market is expected to be driven by cases of haemorrhagic stroke. While rates of incidence of haemorrhagic stroke are heterogenous across the globe, Low and Middle Income countries (LMIC) such as those in Asia and Africa have been witnessing an upward trend.

Nearly 750,000 strokes take place in the USA every year. During a stroke, one or more regions in the brain may suffer damage, and an individual may experience loss of ability to move to one side of the body depending on the region affected. The damage may be permanent or temporary, and loss of function may be partial or full. Long-term outcome depends on the extent of brain damage, how quickly treatment starts, and several other factors.

A haemorrhagic stroke is also known as an intracerebral haemorrhage, or an ICH. It takes place when a blood vessel ruptures and blood gathers in the tissue around the rupture, exerting pressure on the brain and causing loss of blood to surrounding areas. Immediate medical treatment may improve chances of recovery. Prevention is also important. Controlling risk factors may also significantly reduce the chances of having a stroke. The need to treat and manage cases of stroke is expected to drive the global haemorrhagic stroke treatment market.

Symptoms of haemorrhagic stroke include partial or complete loss of consciousness; vomiting; sudden, acute headache; nausea; weakness or numbness in the face, leg, or arm on one side of the body; dizziness; loss of balance; seizures; difficulty with speech or swallowing; and disorientation or confusion.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

A blood vessel in the brain may get ruptured due to aneurysm; it is the more common cause of haemorrhagic stroke. A less common cause of haemorrhagic stroke is an arteriovenous malformation (AVM). This takes place when arteries and veins are connected abnormally without capillaries between them. AVMs are congenital, but not hereditary.

Once a haemorrhagic stroke is controlled with the help of emergency care, further treatment measures may be taken. If the rupture is small and causes little bleeding and pressure, only supportive care may be needed. Such care may include IV fluids, rest, management of other medical problems, and speech, physical, or occupational therapy.

Serious cases of stroke may require surgery. Surgery may be performed if the stroke is caused by an AVM. However, surgery depends on the AVM’s location, and may not always be possible. Surgery may also be warranted to alleviate pressure caused by bleeding and brain swelling.

Today, leading companies offer advanced haemorrhagic stroke products that help manage the problem. Such products include Pipeline™ Vantage Embolization Device with SHIELD TECHNOLOGY™, Pipeline Flex Embolization Device, and Axium Detachable Coils, among others.

Medications for haemorrhagic stroke include Beta Blockers, Alpha Activity; Vasodilators; Anticonvulsants, Other; Anticonvulsants, Hydantoins; Beta Blockers, Beta-1 Selective; Calcium Channel Blockers; Angiotensin Receptor Blockers; and Angiotensin-converting Enzyme Inhibitors, among others. Modern treatment options and solutions are expected to drive the global haemorrhagic stroke treatment market.

Market Analysis by Type, Distribution Channel and Region:

• By type, the market is segmented into Antihypertensive, Anticoagulants, Anticonvulsants, and Others.
• By distribution channel, the market is divided into Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies.
• By region, the market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790